Cancer Trials US FDA Guidances Aim To Expand Eligibility Criteria And Better Inform Labeling

Cancer Trials: US FDA Guidances Aim To Expand Eligibility Criteria And Better Inform Labeling

11:40 EDT 14 Mar 2019 | SCRIP

Draft guidances reflect the agency’s thinking on when patients with HIV/hepatitis infection, brain metastasis, organ dysfunction or prior malignancies, as...

Cancer Trials US FDA Guidances Aim To Expand Eligibility Criteria And Better Inform Labeling

Cancer Trials: US FDA Guidances Aim To Expand Eligibility Criteria And Better Inform Labeling

More From BioPortfolio on "Cancer Trials: US FDA Guidances Aim To Expand Eligibility Criteria And Better Inform Labeling"